Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo-pituitary-adrenocortical axis

被引:57
作者
Barkhudaryan, N
Dunn, AJ [1 ]
机构
[1] Louisiana State Univ, Med Ctr, Dept Pharmacol & Therapeut, Shreveport, LA 71130 USA
[2] NAS RA, Inst Biochem, Yerevan 375014, Armenia
关键词
interleukin-6; serotonin; CRF; endorphins; glutamate;
D O I
10.1023/A:1020720722209
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Biological activities of the multifunctional cytokine, interleukin-6 (IL-6) include stimulation of B cell proliferation, immunoglobulin production, and initiation of the acute-phase response. IL-6 affects the CNS in that it activates the hypothalamo-pituitary-adrenocortical (HPA) axis and increases brain tryptophan and serotonin metabolism. IL-6 has been proposed as an important mediator of interaction between the neuroendocrine and immune systems. The peripheral and central effects of IL-6 are presumably mediated through its membrane receptor (IL-6R). IL-6, IL-6R and their respective mRNAs have been detected in several brain regions. Although the functions of cytokines overlap considerably, each displays its own characteristic properties. Expression of IL-6 in the brain has been observed in several CNS disorders, some of which have been associated with disorders of serotonin metabolism. It is proposed that interactions between IL-6 and brain serotonin is a complex process which involves corticotropin-releasing factor (CRF) and opioid peptides. It is likely that the molecular mechanisms underlying the actions of IL-6 on the HPA axis and its other brain functions involve the integrated effects of glutamate, Ca2+, 3',5'-cyclic AMP, protein kinase C, and other metabolic pathways.
引用
收藏
页码:1169 / 1180
页数:12
相关论文
共 183 条
[1]   Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells [J].
Aghajanian, GK ;
Marek, GJ .
NEUROPHARMACOLOGY, 1997, 36 (4-5) :589-599
[2]   INTERLEUKIN-6 IN BIOLOGY AND MEDICINE [J].
AKIRA, S ;
TAGA, T ;
KISHIMOTO, T .
ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 :1-78
[3]   IL-6 AND NF-IL6 IN ACUTE-PHASE RESPONSE AND VIRAL-INFECTION [J].
AKIRA, S ;
KISHIMOTO, T .
IMMUNOLOGICAL REVIEWS, 1992, 127 :25-50
[4]   EVIDENCE FOR CENTRAL AND PERIPHERAL SEROTONERGIC CONTROL OF CORTICOSTERONE SECRETION IN THE CONSCIOUS RAT [J].
ALPER, RH .
NEUROENDOCRINOLOGY, 1990, 51 (03) :255-260
[5]   ROLE FOR BRAIN CORTICOTROPIN-RELEASING FACTOR IN THE WEIGHT-REDUCING EFFECTS OF CHRONIC FENFLURAMINE TREATMENT IN RATS [J].
APPEL, NM ;
OWENS, MJ ;
CULP, S ;
ZACZEK, R ;
CONTRERA, JF ;
BISSETTE, G ;
NEMEROFF, CB ;
DESOUZA, EB .
ENDOCRINOLOGY, 1991, 128 (06) :3237-3246
[6]   SEROTONIN AGONISTS CAUSE PARALLEL ACTIVATION OF THE SYMPATHOADRENOMEDULLARY SYSTEM AND THE HYPOTHALAMO-PITUITARY-ADRENOCORTICAL AXIS IN CONSCIOUS RATS [J].
BAGDY, G ;
CALOGERO, AE ;
MURPHY, DL ;
SZEMEREDI, K .
ENDOCRINOLOGY, 1989, 125 (05) :2664-2669
[7]  
Barton BE, 1996, MED RES REV, V16, P87, DOI 10.1002/(SICI)1098-1128(199601)16:1<87::AID-MED3>3.0.CO
[8]  
2-Q
[9]   THE ACUTE-PHASE RESPONSE [J].
BAUMANN, H ;
GAULDIE, J .
IMMUNOLOGY TODAY, 1994, 15 (02) :74-80
[10]  
Behan DP, 1996, MOL PSYCHIATR, V1, P265